These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 368881)

  • 1. Pharmacology of fibrinolytic agents.
    Barlow GH
    Prog Cardiovasc Dis; 1979; 21(5):315-26. PubMed ID: 368881
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic agents.
    Schmitz-Huebner U; van de Loo J
    Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacology of fibrinolytics].
    Klöcking HP
    Z Gesamte Inn Med; 1979 Jan; 34(1):22-8. PubMed ID: 373275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of fibrinolysis.
    Haire WD
    Chest; 1992 Apr; 101(4 Suppl):91S-97S. PubMed ID: 1555484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavior of postoperative adhesions after intraperitoneal administration of fibrinolytic drugs in a rat model].
    Stapel A; Geissler N; Mlasowsky B; Jung D
    Langenbecks Arch Chir; 1997; 382(1):33-6. PubMed ID: 9157230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of thrombolytic drugs.
    Verstraete M; Collen D
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):33B-40B. PubMed ID: 3097100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation by fibrinolytic agents: a potential mechanism for resistance to thrombolysis and reocclusion after successful thrombolysis.
    Leopold JA; Loscalzo J
    Coron Artery Dis; 1995 Dec; 6(12):923-9. PubMed ID: 8723013
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel thrombolytic agents.
    Collen D; De Bono DP; Lijnen HR; Pannekoek H
    J Intern Med; 1994 Oct; 236(4):433-7. PubMed ID: 7931045
    [No Abstract]   [Full Text] [Related]  

  • 11. Ancrod enhances the thrombolytic effect of streptokinase and urokinase.
    Cercek B; Lew AS; Hod H; Yano J; Lewis B; Reddy KN; Ganz W
    Thromb Res; 1987 Aug; 47(4):417-26. PubMed ID: 3660351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems of thrombolytic therapy.
    Neilson RF; Davidson JF
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):51-64. PubMed ID: 8920633
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of thrombolytic agents. Implications for therapy of coronary artery thrombosis.
    Marder VJ
    Circulation; 1983 Aug; 68(2 Pt 2):I2-5. PubMed ID: 6683134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of fibrinolytic agents.
    Sasahara AA; Wall RT; Harburg CB
    West J Med; 1981 Feb; 134(2):128-33. PubMed ID: 7222662
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of platelet-inhibitory drugs, anticoagulants, and thrombolytic agents.
    Mehta JL; Kitchens CS
    Cardiovasc Clin; 1987; 18(1):163-79. PubMed ID: 3111692
    [No Abstract]   [Full Text] [Related]  

  • 16. Saruplase versus other fibrinolytic agents.
    Michels HR
    Int J Clin Pract Suppl; 1998 Nov; 99():21-2. PubMed ID: 10344037
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on fibrinolytic agent-platelet interaction (author's transl)].
    Mishina Y; Watada M
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):154-60. PubMed ID: 4277931
    [No Abstract]   [Full Text] [Related]  

  • 18. [Synthetic compounds with fibrinolytic and thrombolytic activity. I. Pharmacologic observations].
    Desnoyers P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):351-6. PubMed ID: 63421
    [No Abstract]   [Full Text] [Related]  

  • 19. Theoretic and practical considerations on laboratory monitoring of thrombolytic therapy.
    Conard J; Samama MM
    Semin Thromb Hemost; 1987 Apr; 13(2):212-22. PubMed ID: 3114887
    [No Abstract]   [Full Text] [Related]  

  • 20. The acyl-enzymes and pro-urokinase: promising new thrombolytic agents.
    Samama M; Horellou MH; Nguyen G; Conard J
    Haemostasis; 1986; 16 Suppl 3():33-7. PubMed ID: 3095196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.